Objective This study aims to understand the attitudes, stigma, and discrimination of the general adult population toward drug addiction.Methods We conducted a cross-sectional nationwide survey with 1,020 Korean adults using an Internet web-based panel. Self-reported data were collected on demographics, experience with substance abuse, perceptions of narcotic analgesic use, beliefs about the legalization of cannabis use, coping with substance abuse and addiction, and perceptions of drug risks. All statistical analysis in this study utilized the IBM SPSS Statistics 26 program.Results In this study, 1.6% of the participants reported abuse of opioid analgesics, 88.0% reported negative perceptions of drug addiction, and 76.9% reported agreeing to unfair treatment of drug addicts. Logistic regression analysis found that perceived stigma was more prevalent among women (odd ratio [OR]=2.087, p<0.01), old adults (OR=1.939, p<0.01), those with no personal experience of opioid misuse (OR=8.172, p<0.05), and those who were non-smoking (OR=2.011, p<0.01). In addition, the discriminatory attitude was more prevalent among participants with higher income (OR=1.989, p<0.001) and those who are non-smoking (OR=1.608, p<0.05).Conclusion This study provides information and guidelines for public intervention in drug addiction by identifying factors influencing social stigma and discriminatory behaviors toward drug addiction. The findings suggest that education on drug addiction prevention for the general adult population is necessary, and this education should include knowledge on coping with drug addiction and reducing stigma and discrimination toward drug addicts.
Background: Although digital cognitive behavioral therapy (dCBT) is considered effective for anxiety disorders, there is considerable heterogeneity in its efficacy across studies, and its varied treatment content and clinical components may explain such heterogeneity. Objective: This review aimed to identify the efficacy of digital cognitive behavioral therapy for panic disorder and agoraphobia, and examine whether applying relevant clinical components of interoceptive exposure, inhibitory-learning-based exposure, and personalization of treatment enhances its efficacy. Methods: Randomized controlled trials of dCBT for panic disorder and agoraphobia with passive or active controls were identified from OVID Medline, Embase, Cochrane Library, and PsycINFO. The overall effect sizes for dCBT groups (interventions through digital platforms based on the internet, mobile, computers, VR, etc.) were aggregated against passive control (placebo/sham) and active control (traditional CBT) groups. For subgroup analysis, key intervention components such as interoceptive exposure, inhibitory learning, and personalization were assessed dichotomously (0 or 1) along with other study characteristics. The stepwise meta-regression models were applied with traditional and Bayesian statistical testing. The risk of bias and publication bias of included studies were assessed. Results: Among the 31 selected studies, dCBT had an overall effect size of g = 0.70 against passive control and g = −0.05 against active control. In subgroup analysis, interoceptive exposure improved the clinical effects for both controls, and inhibitory learning and personalization increased the clinical effects for passive control along with therapist guide/support and the length of sessions. Many studies were vulnerable to therapist bias and attrition bias. No publication bias was detected. Conclusions: The heterogeneity in clinical effects of dCBT for panic and agoraphobia can be explained by the different intervention factors they include. For effective dCBT, therapists should consider the clinical components relevant to the treatment.
Objectives: Virtual reality (VR) has emerged as a promising tool for assessing anxiety-related disorders through immersive exposure and physiological monitoring. This study aimed to evaluate whether multimodal data, including heart rate variability (HRV), skin conductance response (SCR), and self-reported anxiety, collected during VR exposure could classify patients with panic disorder and agoraphobia using machine learning models. Methods: Seventy-six participants (38 patients with panic disorder and agoraphobia, 38 healthy controls) completed 295 total VR exposure sessions. Each session involved two road and two supermarket scenarios designed to induce anxiety. Inside the sessions, self-reported anxiety was measured along with physiological signals recorded by photoplethysmography and SCR sensors. HRV measures of heart rate, standard deviation of normal-to-normal intervals, and low-frequency to high-frequency ratio were extracted along with SCR peak frequency and average amplitude. These features were analyzed using Gaussian Naïve Bayes (GNB), k-Nearest Neighbors (k-NN), Logistic Ridge Regression (LRR), C-Support Vector Machine (SVC), Random Forest (RF), and Stochastic Gradient Boosting (SGB) classifiers. Results: The best model achieved an accuracy of 0.83. Most models showed specificity and precision ≥0.80, while sensitivity varied across models, with several reaching ≥0.82. Performance was stable across major hyperparameters, VR-stimulus settings, and medication status. The patients reported higher subjective anxiety but exhibited blunted physiological responses, particularly in SCR amplitude. Self-reported anxiety demonstrated higher feature importance scores compared to other physiological properties. Conclusion: VR exposure with self-reported anxiety and physiological measures may serve as a feasible diagnostic aid for panic disorder and agoraphobia. Further refinement is needed to improve sensitivity and clinical applicability.